Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey.

Barrière, J; Gal, J; Hoch, B; Cassuto, O; Leysalle, A; Chamorey, E; Borchiellini, D

Barrière, J; Gal, J; Hoch, B; Cassuto, O; Leysalle, A; Chamorey, E; Borchiellini, D.

Afiliação

Barrière J; Department of Medical Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France. Electronic address: j.barriere@polesantesaintjean.fr.
Gal J; Department of Biostatistics and Epidemiology, Centre Antoine Lacassagne, Nice, France.
Hoch B; Department of Medical Oncology, Centre Azuréen de Cancérologie, Mougins, France.
Cassuto O; Department of Medical Oncology, Clinique Saint George, Nice, France.
Leysalle A; Department of Medical Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France.
Chamorey E; Department of Biostatistics and Epidemiology, Centre Antoine Lacassagne, Nice, France.
Borchiellini D; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.

Ann Oncol ; 32(5): 673-674, 2021 05.

Article em En | MEDLINE | ID: mdl-33529740

Assuntos

COVID-19; Neoplasias; Vacinas contra COVID-19; Estudos Transversais; Humanos; SARS-CoV-2; Vacinação

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google